In contrast, NRG-4 transgenic mice show enhanced whole body glucose metabolism and, consequently, reduced obesity and insulin resistance compared to control animals (Wang et al., 2014; Chen et al., 2017). Here, NRG4 is linked to obesity due to melanocortin 4 receptor deficiency.